HUP9801629A3 - Methods and compositions for regulation of cd28 expression - Google Patents

Methods and compositions for regulation of cd28 expression

Info

Publication number
HUP9801629A3
HUP9801629A3 HU9801629A HUP9801629A HUP9801629A3 HU P9801629 A3 HUP9801629 A3 HU P9801629A3 HU 9801629 A HU9801629 A HU 9801629A HU P9801629 A HUP9801629 A HU P9801629A HU P9801629 A3 HUP9801629 A3 HU P9801629A3
Authority
HU
Hungary
Prior art keywords
regulation
expression
compositions
methods
Prior art date
Application number
HU9801629A
Other languages
Hungarian (hu)
Original Assignee
Icn Pharmaceuticals Inc Costa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icn Pharmaceuticals Inc Costa filed Critical Icn Pharmaceuticals Inc Costa
Publication of HUP9801629A2 publication Critical patent/HUP9801629A2/en
Publication of HUP9801629A3 publication Critical patent/HUP9801629A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/13—Decoys
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
    • C12N2310/151—Nucleic acids forming more than 2 strands, e.g. TFOs more than 3 strands, e.g. tetrads, H-DNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/18—Type of nucleic acid acting by a non-sequence specific mechanism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HU9801629A 1995-02-09 1996-02-05 Methods and compositions for regulation of cd28 expression HUP9801629A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38704195A 1995-02-09 1995-02-09

Publications (2)

Publication Number Publication Date
HUP9801629A2 HUP9801629A2 (en) 1998-10-28
HUP9801629A3 true HUP9801629A3 (en) 2000-10-30

Family

ID=23528194

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9801629A HUP9801629A3 (en) 1995-02-09 1996-02-05 Methods and compositions for regulation of cd28 expression

Country Status (4)

Country Link
EP (1) EP0810882A4 (en)
HU (1) HUP9801629A3 (en)
PL (1) PL321711A1 (en)
WO (1) WO1996024380A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
IT1277025B1 (en) * 1995-12-04 1997-11-04 Cooperativa Centro Ricerche Po CLASS OF PHOSPHODIESTERIC OLIGONUCLEOTIDES WITH CYTOTOXIC ACTIVITY PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE
PL334197A1 (en) * 1996-12-27 2000-02-14 Icn Pharmaceuticals Oligonucleotidic aptamers of high g content and methods of modulating immunilogical response
AU777225B2 (en) * 1998-09-03 2004-10-07 Coley Pharmaceutical Gmbh G-motif oligonucleotides and uses thereof
EP1366077B1 (en) 2000-09-15 2011-05-25 Coley Pharmaceutical GmbH PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
WO2011011700A2 (en) * 2009-07-24 2011-01-27 Curna, Inc. Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
WO2011038210A2 (en) 2009-09-25 2011-03-31 Curna, Inc. Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity
WO2014090985A1 (en) * 2012-12-13 2014-06-19 Universität Leipzig T-cell modulation by exon skipping

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0575537A1 (en) * 1991-03-08 1993-12-29 Cytomed, Inc. Soluble cd28 proteins and methods of treatment therewith
US6664107B1 (en) * 1993-05-26 2003-12-16 Ontario Cancer Institute, University Health Network CD45 disrupted nucleic acid

Also Published As

Publication number Publication date
PL321711A1 (en) 1997-12-22
EP0810882A1 (en) 1997-12-10
HUP9801629A2 (en) 1998-10-28
WO1996024380A1 (en) 1996-08-15
EP0810882A4 (en) 1999-05-19

Similar Documents

Publication Publication Date Title
AU5529596A (en) Methods and compositions related to stereolithography
PL323736A1 (en) Composition maintaining release of non-aggregable erythropoietin
IL117872A0 (en) Herbicidal compositions and method of their use
AU7471096A (en) Compositions and methods for treating bone deficit conditions
AU5439996A (en) Compositions and methods for treating pain
AU5404094A (en) Method for controlling o-desulfation of heparin and compositions produced thereby
ZA96737B (en) Cosmetic compositions for reducing or preventing signs of cullulite
AU4751296A (en) Method of suspending inclusions and compositions produced thereby
AU6485996A (en) Methods and compositions for modulation and inhibition of teomerase
GB9508791D0 (en) Compositions of matter
EP0777473A4 (en) Compositions and methods for the control of smoking
AU3117600A (en) Composition and method for regulation of body weight and associated conditions
PL324461A1 (en) Synergic herbicidal composition and method of using same
GB9521991D0 (en) Underarm compositions
HUP9801629A3 (en) Methods and compositions for regulation of cd28 expression
AU4468093A (en) Composition and methods for the generation of bone
HUP9603529A2 (en) Femoral part of hip-joint-prothesis
GB9507297D0 (en) New composition of matter
IL110887A0 (en) Method for regulation of NF-AlphaB
GB9517111D0 (en) Surface-coating composition and method of application
IL113057A0 (en) Compositions for the treatment of dandruff
ZA963073B (en) Coating compositions and methods of using them
GB9510162D0 (en) Compositions for the treatment of skin conditions
CZ250097A3 (en) Processes and compositions for regulation of cd28 expression
ZA963825B (en) Composition of matter